2025년도 쇼트코스

 

Monday, 10 November, 2025

SC1: Best Practices and Advanced Applications for Label-Free Interaction Analysis in Therapeutic Antibody Discovery

Yasmina Abdiche, PhD, Senior Vice President, Exploratory Research, OmniAb Inc.

SC2: Best Practices for Targeting GCPRs, Ion Channels, and Transporters with Monoclonal Antibodies

Ross Chambers, PhD, Vice President, Antibody Discovery, Integral Molecular, Inc.

SC3: Developability of Bispecific Antibodies

Nimish Gera, PhD, Vice President, Biologics, Mythic Therapeutics

SC4: In silico and Machine Learning Tools for Antibody Design and Developability Predictions

Rahmad Akbar, PhD, Senior Data Scientist, Antibody Design, Novo Nordisk
Vinodh B. Kurella, PhD, Biotherapeutic Computational Modeler, Takeda Pharmaceuticals, Inc.
Odysseas Vavourakis, Generative Antibody Design, University of Oxford

SC5: Novel Payloads and Conjugation Strategies - Building on Lessons Learned to Inform Next-Generation ADC Design

Lenka Sadilkova, PhD, Head, Preclinical R&D, Mablink

* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_

9월 12일까지
조기신청할인
최대 €400 OFF
Present a Poster
전체 스폰서 보기
전체 미디어 파트너 보기

컨퍼런스 프로그램

Engineering

공학 스트림

Targets

타겟 스트림

Bispecifics

이중특이성 스트림

Immunotherapy

면역치료 스트림

Analytical

분석법 스트림

Expression

발현 스트림

Machine Learning

기계학습 스트림

Oncology

종양 스트림

Short Courses
Training Seminars

Catalog Download
Catalog